AbbVie Inc.: operating_income
| Value | {"amount": 9545000000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | current |
| Entity | AbbVie Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:44:37.484490+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e9f91ae1-098c-4f7d-ac94-2e9c6f4a4615
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001551152-19-000008Retrieved: 2026-08-19T15:44:37.484490+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001551152/operating-income/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e9f91ae1-098c-4f7d-ac94-2e9c6f4a4615
History
- supersedes {"amount": 9592000000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001551152-18-000014)